Injection medicament for treating chronic lymphoid thyreoitis

A thyroiditis and lymphatic technology, applied in the field of injection drugs for the treatment of chronic lymphocytic thyroiditis, can solve problems such as not recommended use, and achieve the effect of less hormone stimulation

Inactive Publication Date: 2010-04-21
曲卫
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Glucocorticoids can shrink the enlarged thyroid gland and reduce the antibody titer, but it is generally not recommended due to the side effects after medication and the relapse of the disease after drug withdrawal.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Dissolve 40 mg of methylprednisolone sodium succinate for injection and 0.2 g of cyclophosphamide for injection in 10 ml of 2% lidocaine injection, and mix them evenly.

[0034] Usage and Dosage: Take local injection to the thyroid gland, inject 0.5-1ml each time on each side of the bilateral thyroid gland, once a week, and inject twice a week in severe cases. It is injected once every two weeks or twice a week until the symptoms are cured or markedly effective.

Embodiment 2

[0036] Dissolve 80 mg of methylprednisolone sodium succinate for injection and 0.4 g of cyclophosphamide for injection in 20 ml of 2% lidocaine injection, and mix them uniformly.

[0037] Usage and Dosage: Take local injection to the thyroid gland, inject 0.5-1ml each time on each side of the bilateral thyroid gland, once a week, and inject twice a week in severe cases. It is injected once every two weeks or twice a week until the symptoms are cured or markedly effective.

Embodiment 3

[0039] Dissolve 60 mg of methylprednisolone sodium succinate for injection and 0.3 g of cyclophosphamide for injection in 15 ml of 2% lidocaine injection, and mix them evenly.

[0040] Usage and Dosage: Take local injection to the thyroid gland, inject 0.5-1ml each time on each side of the bilateral thyroid gland, once a week, and inject twice a week in severe cases. It is injected once every two weeks or twice a week until the symptoms are cured or markedly effective.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicament for injection, in particular to an injection medicament for treating chronic lymphoid thyreoitis. The medicament is prepared by mixing methylprednisolone sodium succinate for injection, cyclophosphamide for injection and 2 percent lignocaine injection in certain mixing ratio. The medicament is injected locally, and medicinal strength cannot involve the whole body, which is favorable for deferring and protecting other parts of the body against medicament erosion and has small hormone irritability.

Description

(1) Technical field [0001] The invention relates to an injection medicine, in particular to an injection medicine for treating chronic lymphatic thyroiditis. (2) Background technology [0002] Chronic lymphatic thyroiditis, also known as autoimmune thyroiditis and Hashimoto's disease, is a relatively common organ-specific autoimmune thyroid disease. 90% of patients are women, and most of them are between 30 and 50 years old. Children can also occur. The clinical manifestations of this disease are: onset is slow, patients generally have no special feeling, and goiter is often discovered unintentionally, generally showing diffuse symmetrical enlargement. When the thyroid gland is destroyed to a certain extent, more than half of the patients may develop thyroid function in the later stage Decreased symptoms, fatigue, drowsiness, fear of cold, poor memory, mental decline, pale skin with cool dry thick, loss of appetite and weight gain, breast swelling but no depression, severe ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/675A61K31/573A61K31/167A61P5/14A61P37/02
Inventor 曲卫
Owner 曲卫
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap